Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RTTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
B3GALNT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIR-FIGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD51L3-RFFL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PET117 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
YAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PLPP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
URB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on